Birth Defects Research

Papers
(The H4-Index of Birth Defects Research is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
95
Believing in science30
Protective Role of Vitamin B6 Against Teratogenic Effects Induced by Lead in Chick Embryo29
27
Reply to Correspondence “Beyond Aggregate Risk: Drug‐ and Organ‐Specific Nuances in Counseling on Antidepressant Teratogenicity” (Tsai et al. 2025)26
Community‐Engaged Research and the Use of Open Access ToxVal/ToxRef In Vivo Databases and New Approach Methodologies (NAM) to Address Human Health Risks From Environme25
Prenatal Exposure to Methamphetamine and Its Association With Birth Outcomes: A Meta‐Analysis25
How Does Maternal Lipopolysaccharide Exposure Impact Prenatal Testicular Development in Rats, and Could α‐Tocopherol Provide a Protective Effect? A Histological, Immunohistochemical and Biochemical St25
Domestic Use of Solvents and Pesticides and the Risk of Hypospadias in Offspring: A Case–Control Study From Brittany, France24
Maternal cigarette smoking and alcohol consumption and congenital diaphragmatic hernia22
Society for birth defects research and prevention's multidisciplinary research needs workshop 2022: A call to action21
Developmental exposure to the flame retardant, triphenyl phosphate, causes long‐lasting neurobehavioral and neurochemical dysfunction20
A Case Report: Co‐Occurrence of TNRC6B Gene Variant and Xq28 Microdeletion Syndrome With Comprehensive Literature Review19
Issue Information18
In vitro fertilization and pregnancy outcomes of women with X chromosome abnormality: A case series17
17
Why Has Gastroschisis Increased Over Time and Why Is It More Common in Infants of Young Mothers?16
Potential risk factors for hypospadias and negative correlation with DICER1 (rs3742330) A>G variant in Algerian population: A case‐control study16
Reversible effects on female rat fertility with abrocitinib, a Janus kinase 1 inhibitor16
0.10132193565369